Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.

Atrial fibrillation Hypertrophic cardiomyopathy Late gadolinium enhancement Left atrial volume index

Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
13 Jun 2024
Historique:
received: 13 03 2024
revised: 07 05 2024
accepted: 12 06 2024
medline: 16 6 2024
pubmed: 16 6 2024
entrez: 15 6 2024
Statut: aheadofprint

Résumé

Atrial fibrillation (AF) increases stroke and mortality in patients with hypertrophic cardiomyopathy (HCM). Cardiac MRI (CMR) is increasingly used to detect late gadolinium enhancement (LGE) as a reliable indicator of left ventricular fibrosis, a potential predisposing factor of AF. Our research explored the correlation between left ventricular LGE and AF prevalence in HCM. This retrospective study involved 351 HCM patients who underwent CMR. LGE percentages (0%, 1-5%, 6-14%, ≥15%) on CMR were compared with AF prevalence in HCM patients. Demographic, comorbidity, and imaging data were analyzed using appropriate univariate and multivariate analyses assessing for significant differences in AF prevalence. The predetermined significance level was p < 0.05. CMR demonstrated increased LGE in those with AF (p = 0.004). Increased LGE correlated with increased AF rates: 27.6% (0% LGE), 38.5% (1-5% LGE), 44.4% (6-14% LGE), and 54.7% (≥15% LGE) (p = 0.101, p = 0.043, p = 0.002, respectively, vs. 0% LGE). Adjusted for age, differences persisted and were most evident for LGE >15% (p = 0.001). Multivariate analysis, factoring age, gender, BMI, RVSP, and LVEF, supported LGE (odds ratio of 1.20, p = 0.036) and LAVI (odds ratio 1.05, 1.02-1.07, p < 0.001) as predictive markers for AF prevalence. Our study suggests a correlation between ventricular LGE and AF in patients with HCM. LGE exceeding 15% was associated with a significant increase in AF prevalence. These patients may require more frequent AF monitoring.

Sections du résumé

BACKGROUND BACKGROUND
Atrial fibrillation (AF) increases stroke and mortality in patients with hypertrophic cardiomyopathy (HCM). Cardiac MRI (CMR) is increasingly used to detect late gadolinium enhancement (LGE) as a reliable indicator of left ventricular fibrosis, a potential predisposing factor of AF. Our research explored the correlation between left ventricular LGE and AF prevalence in HCM.
METHODS METHODS
This retrospective study involved 351 HCM patients who underwent CMR. LGE percentages (0%, 1-5%, 6-14%, ≥15%) on CMR were compared with AF prevalence in HCM patients. Demographic, comorbidity, and imaging data were analyzed using appropriate univariate and multivariate analyses assessing for significant differences in AF prevalence. The predetermined significance level was p < 0.05.
RESULTS RESULTS
CMR demonstrated increased LGE in those with AF (p = 0.004). Increased LGE correlated with increased AF rates: 27.6% (0% LGE), 38.5% (1-5% LGE), 44.4% (6-14% LGE), and 54.7% (≥15% LGE) (p = 0.101, p = 0.043, p = 0.002, respectively, vs. 0% LGE). Adjusted for age, differences persisted and were most evident for LGE >15% (p = 0.001). Multivariate analysis, factoring age, gender, BMI, RVSP, and LVEF, supported LGE (odds ratio of 1.20, p = 0.036) and LAVI (odds ratio 1.05, 1.02-1.07, p < 0.001) as predictive markers for AF prevalence.
CONCLUSIONS CONCLUSIONS
Our study suggests a correlation between ventricular LGE and AF in patients with HCM. LGE exceeding 15% was associated with a significant increase in AF prevalence. These patients may require more frequent AF monitoring.

Identifiants

pubmed: 38878873
pii: S0167-5273(24)00885-4
doi: 10.1016/j.ijcard.2024.132263
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132263

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest This study was supported by a grant from the DeVos Foundation to the Cardiovascular Research Program of the Heart and Vascular Institute, Corewell Health West. The authors report no relationships that could be construed as a conflict of interest.

Auteurs

Matthew Hollowell (M)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA; Michigan State University, Grand Rapids, MI, USA.

Joseph Banno (J)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA; Michigan State University, Grand Rapids, MI, USA.

Dana Marsy (D)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Nabin Shrestha (N)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Jose Tan (J)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Richard McNamara (R)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Jeffrey Decker (J)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Alfred Albano (A)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Laura Franey (L)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Wissam Abdallah (W)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Renzo Loyaga-Rendon (R)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.

Nagib Chalfoun (N)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA; Michigan State University, Grand Rapids, MI, USA.

David Fermin (D)

Corewell Health West Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA. Electronic address: david.fermin@corewellhealth.org.

Classifications MeSH